Gilead Sciences
GILD
#129
Rank
โ‚น13.512 T
Marketcap
โ‚น10,890
Share price
-1.14%
Change (1 day)
40.82%
Change (1 year)

Gilead Sciences (GILD) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น2.240 Trillion

According to Gilead Sciences's latest financial reports the company's total debt is โ‚น2.240 Trillion. A companyโ€™s total debt is the sum of all current and non-current debts.

Gilead Sciences - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น2.291 T10.16%
2023-12-31โ‚น2.080 T-0.37%
2022-12-31โ‚น2.087 T5.08%
2021-12-31โ‚น1.986 T-13.48%
2020-12-31โ‚น2.296 T30.95%
2019-12-31โ‚น1.753 T-8.2%
2018-12-31โ‚น1.910 T-10.8%
2017-12-31โ‚น2.141 T19.62%
2016-12-31โ‚น1.790 T22.15%
2015-12-31โ‚น1.465 T86.44%
2014-12-31โ‚น786.14 B91.75%
2013-12-31โ‚น409.97 B-8.95%
2012-12-31โ‚น450.29 B11.89%
2011-12-31โ‚น402.42 B157.7%
2010-12-31โ‚น156.15 B169.58%
2009-12-31โ‚น57.92 B3.87%
2008-12-31โ‚น55.76 B8.32%
2007-12-31โ‚น51.48 B-17.59%
2006-12-31โ‚น62.47 B361.46%
2005-12-31โ‚น13.53 B75227.75%
2004-12-31โ‚น17.97 M-99.89%
2003-12-31โ‚น15.72 B-44.92%
2002-12-31โ‚น28.55 B134.95%
2001-12-31โ‚น12.15 B2.01%
2000-12-31โ‚น11.91 B211.51%
1999-12-31โ‚น3.82 B-11.38%
1998-12-31โ‚น4.31 B3331.76%
1997-12-31โ‚น0.12 B-46.18%
1996-12-31โ‚น0.23 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
โ‚น4.903 T 118.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น164.83 B-92.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น6.175 T 175.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น231.41 B-89.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น592.03 B-73.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.466 T 143.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น4.114 T 83.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.818 T 70.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น3.716 T 65.89%๐Ÿ‡บ๐Ÿ‡ธ USA